Nordson EFD Introduces the Contact versus Jet Dispensing White Paper
Nordson EFD , a Nordson company (NASDAQ: NDSN), the world’s leading precision fluid dispensing systems manufacturer, is pleased to introduce its Contact vs. Jet Dispensing white paper.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190425005027/en/
As products continue to get smaller and smaller, Nordson EFD has developed new solutions to address this growing need to apply precise, repeatable micro-deposits of assembly fluids in production processes worldwide.
“We understand the challenges manufacturers face when their process requires bonding tiny substrates and components together,” said Peter Langer, Business Unit Director of Valves at Nordson EFD. “The deposit tolerance requirements are considerable. And there are a number of variables to consider in order to choose the right dispensing method.”
This white paper helps manufacturers understand the difference between two of the most common dispensing methods. Contact dispensing, for example, allows users to dispense extremely tiny amounts of fluid consistently. The tradeoffs include slower cycle rates and possible part damage due to the need for Z-axis movement of an automated system.
Jet dispensing benefits include highly precise, repeatable micro-dispensing at speeds up to 1000Hz continuous. Jetting also meets exact deposit tolerances as small as +/- 1%. Tradeoffs include the fact that some fluids, such as those filled with highly-abrasive particles, cannot be jetted efficiently.
Getting an experienced fluid application specialist involved early in the process of selecting a dispensing system can prevent many issues that could occur later in production.
For more information, email Nordson EFD at info@nordsonefd.com, or call +1 401.431.7000 or 800.556.3484.
About Nordson EFD
Nordson EFD designs and manufactures precision
fluid dispensing systems for benchtop assembly processes and
automated assembly lines. By enabling manufacturers to apply the same
amount of adhesive, lubricant or other assembly fluid to every part,
every time, EFD dispensing systems are helping companies in a wide
variety of industries increase throughput, improve quality, and lower
their production costs. Other fluid management capabilities include
high-quality syringe
barrels and cartridges
for packaging one- and two-component materials, along with a wide
variety of fittings,
couplers and connectors for controlling fluid flow in medical,
biopharmaceutical and industrial environments. The company is also a
leading formulator of specialty solder
pastes for dispensing and printing applications in the electronics
industry.
About Nordson Corporation
Nordson engineers, manufactures,
and markets differentiated products and systems used for dispensing and
processing adhesives, coatings, polymers, sealants and biomaterials; and
for managing fluids, testing and inspecting for quality, treating
surfaces and curing. These products are supported with extensive
application expertise and direct global sales and service. We serve a
wide variety of consumer non-durable, consumer durable and technology
end markets including packaging, nonwovens, electronics, medical,
appliances, energy, transportation, building and construction, and
general product assembly and finishing. Founded in 1954 and
headquartered in Westlake, Ohio, the company has operations and support
offices in more than 30 countries. Visit Nordson on the web at nordson.com,
twitter.com/Nordson_Corp
or facebook.com/nordson.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190425005027/en/
Contact information
Nordson EFD
Global
Natalie Tomasso
+1-401-431-7173; natalie.tomasso@nordsonefd.com
Europe
+44
(0) 1582 666334; europe@nordsonefd.com
China
+86
(21) 3866 9006; china@nordsonefd.com
Japan
+81
(03) 5762 2760; japan@nordsonefd.com
Korea
+82
(31) 7368321; korea@nordsonefd.com
SEAsia
+65
6796 9522; sin-mal@nordsonefd.com
India
+91
80 4021 3600; india@nordsonefd.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Populous Acquires Fentress Architects, Expanding Global Aviation Portfolio6.6.2025 21:00:00 EEST | Press release
Populous, the world-renowned design firm specializing in sport and entertainment venues, today announced the acquisition of Denver-based Fentress Architects, a global leader in iconic aviation projects and prominent public buildings, including convention centers, museums and government facilities. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250606849000/en/ Los Angeles International Airport. Designed by Fentress Architects. This strategic acquisition unites two of the most respected names in architecture, combining Populous’ unparalleled expertise in designing memorable experiences with Fentress’ award-winning portfolio of aviation, civic and cultural landmarks. The acquisition significantly broadens the scope and scale of services that Populous can offer clients across the globe. Bruce Miller, Populous Global Chair and CEO, commented: “We are committed to expanding the breadth of our practice. Fentress Architects has lon
Vertex Presents New Data on Benefits of ALYFTREK ® and Importance of Achieving Lower Sweat Chloride Levels at the European Cystic Fibrosis Conference6.6.2025 19:00:00 EEST | Press release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data across multiple studies demonstrating positive clinical and quality of life benefits of treatment with CFTR modulators and, in particular, ALYFTREK® (vanzacaftor/tezacaftor/deutivacaftor), which is approved in the United States and United Kingdom and is currently under review with health authorities in the EU, Canada, Australia, New Zealand and Switzerland. These data were presented at this year’s European Cystic Fibrosis Society’s (ECFS) 48th European Cystic Fibrosis Conference held June 4-7, 2025, in Milan, Italy. During the conference, the Company presented data from a pooled analysis across CFTR modulators, including ALYFTREK, which demonstrate that reduction in sweat chloride (SwCl), and therefore greater restoration of CFTR function, is associated with improved outcomes in people with cystic fibrosis (CF). For all clinical outcomes in the study, SwCl levels below 60 mmol/L were associated with greater benefit
IBSA Derma at IMCAS Asia 2025: spotlight on the future of aesthetic medicine in the 10 th Anniversary Year of NAHYCO ® Technology6.6.2025 17:00:00 EEST | Press release
IBSA Derma – the dermoaesthetic division of IBSA – once again confirms its leadership in the international aesthetic medicine landscape by participating in the 18th edition of IMCAS Asia, taking place from June 6 to 8 in Bangkok, Thailand. With over 3,000 attendees expected, the event represents a key opportunity for physicians and experts to share the latest innovations and cutting-edge advancements in aesthetic procedures and treatments, staying at the forefront of this dynamic field. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250603094257/en/ IBSA’s stand at IMCAS Asia 2025 As part of the congress, IBSA Derma will host a scientific symposium titled “The Future of Tissue Regeneration with NAHYCO® Technology. Feeling and Seeing the Results with Profhilo® Line” scheduled for Saturday, June 7, from 3:00 to 4:00 pm ICT in Room 1 - Level 2. Internationally renowned speakers – Dr. Lam Bee Lan and Prof. Ofir Artzi – will lead
HistoSonics Completes Enrollment in #HOPE4KIDNEY Trial Evaluating Non-Invasive Histotripsy to Treat Kidney Tumors6.6.2025 15:00:00 EEST | Press release
HistoSonics, Inc., the manufacturer of the Edison® Histotripsy System and novel histotripsy therapy platforms, today announced the completion of patient enrollment in its pivotal #HOPE4KIDNEY trial. This prospective, multi-center, single-arm trial is designed to evaluate the safety and effectiveness of the Edison System in destroying kidney tissue by treating primary solid kidney tumors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250606659747/en/ Edison Histotripsy System Procedure for Kidney Tumor Animation The trial enrolled patients with a single, non-metastatic solid kidney mass ≤3 cm, confirmed by imaging and biopsy. Subjects will be followed for five years post-procedure, with evaluations at multiple time points, including 14-day, 30-day, 90-day, 180-day, and annual assessments. The Edison System remains in investigational use for kidney applications and is not yet FDA-approved for this indication. Data from the #H
Norwegian Tech Firm Builds Military Command Center in 24 Hours6.6.2025 14:45:00 EEST | Press release
The solution was showcased during a military exercise led by the Dutch Ministry of Defence and has already sparked interest from NATO members and civil protection agencies across Europe. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250606640770/en/ Cyviz demonstrates rapid deployment capability with a mobile, container-based control room for defense and crisis response Cyviz and its partners constructed the command room inside a 14-ton container designed for transport on standard military vehicles and resistant to machine gun fire. The unit was deployed at a military base in the Netherlands, where Cyviz was tasked with delivering a fully functional command-and-control environment, under strict time constraints and in a high-stakes simulation. "You don’t have time to build control rooms from scratch during an emergency. That’s why we designed something that’s mobile, fast to deploy, and fully secure”, says John van Laerhove
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom